1. Home
  2. BCIC vs INGN Comparison

BCIC vs INGN Comparison

Compare BCIC & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCIC

BCP Investment Corporation

N/A

Current Price

$8.02

Market Cap

162.3M

Sector

Finance

ML Signal

N/A

Logo Inogen Inc

INGN

Inogen Inc

HOLD

Current Price

$6.30

Market Cap

168.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCIC
INGN
Founded
2006
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.3M
168.6M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BCIC
INGN
Price
$8.02
$6.30
Analyst Decision
Hold
Strong Buy
Analyst Count
2
4
Target Price
$9.00
$11.25
AVG Volume (30 Days)
149.0K
201.6K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
14.36%
N/A
EPS Growth
N/A
43.42
EPS
N/A
N/A
Revenue
N/A
$348,668,000.00
Revenue This Year
$5.07
$7.92
Revenue Next Year
N/A
$7.86
P/E Ratio
$7.27
N/A
Revenue Growth
N/A
3.86
52 Week Low
$7.11
$5.34
52 Week High
$13.50
$9.13

Technical Indicators

Market Signals
Indicator
BCIC
INGN
Relative Strength Index (RSI) 42.27 49.71
Support Level $7.11 $5.93
Resistance Level $12.33 $6.85
Average True Range (ATR) 0.30 0.33
MACD 0.20 0.02
Stochastic Oscillator 90.20 39.30

Price Performance

Historical Comparison
BCIC
INGN

About BCIC BCP Investment Corporation

BCP Investment Corp is a closed-end, externally managed, non-diversified management investment company. The company invests in performing, well- established middle market businesses that operate across a wide range of industries. It employs fundamental credit analysis, targeting investments in businesses with relatively low levels of cyclicality and operating risk.

About INGN Inogen Inc

Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.

Share on Social Networks: